PCOS Is Now PMOS: What the New Name Means for Your Health
If you have polycystic ovary syndrome or have spent years trying to understand unexplained symptoms you may start hearing a new term: polyendocrine metabolic ovarian syndrome, or PMOS.
In May 2026, experts announced that PCOS would be renamed PMOS. This does not describe a new condition, and it does not mean your diagnosis has changed. Instead, the new name reflects a more accurate understanding of what the condition is, and what it is not.
PMOS is not simply an ovarian condition, and you do not need to have ovarian cysts to have it. It is a complex hormonal and metabolic syndrome that can affect periods, ovulation, skin, hair, insulin regulation, emotional wellbeing and long-term health.
Here is what the change means in practical terms.
Why was PCOS renamed PMOS?
The term "polycystic ovary syndrome" has always been somewhat misleading.
Despite the name, the structures commonly seen on an ultrasound are usually immature ovarian follicles; not true cysts. Some people with the condition do not have this ovarian appearance at all, while others may have it without having the syndrome.
This created understandable confusion. Some women were told that they could not have PCOS because their ultrasound did not show "cysts." Others assumed that the condition only affected their ovaries or fertility.
The new name breaks the condition down more accurately:
- Polyendocrine means that more than one hormonal system may be involved.
- Metabolic recognises the role that insulin regulation and other metabolic factors can play.
- Ovarian acknowledges the condition's effects on ovulation and reproductive health.
- Syndrome means that it can present as a collection of different signs and symptoms.
The international renaming initiative involved patients, healthcare professionals and more than 50 medical and consumer organizations (1). The change is expected to be gradually incorporated into healthcare systems and clinical guidance, so you may continue to see both PCOS and PMOS used during the transition.
What does the latest understanding tell us?
The most important shift is that PMOS should be viewed as a whole-body condition, rather than only a reproductive disorder.
1. PMOS can look different in different people
There is no single PMOS experience.
One woman may mainly experience irregular periods and difficulty ovulating. Another may have acne, increased facial hair or scalp hair thinning. Some women experience insulin resistance or changes in weight, while others, including lean women, may not have obvious metabolic symptoms.
This variation is one reason diagnosis can take time. It also means that care should be based on your individual symptoms, test results and priorities, not a one-size-fits-all "PCOS plan."
2. Insulin resistance matters; but it is not the whole story
Insulin helps glucose move from the bloodstream into cells, where it can be used for energy. When cells become less responsive to insulin, the body may compensate by producing more of it. Higher insulin levels can interact with the ovaries and contribute to increased androgen production, irregular ovulation and other symptoms. However, not everyone with PMOS has the same degree of insulin resistance, and having PMOS is not a sign that you caused it through your diet or weight.
Genetics, hormonal signalling, environment, sleep, stress and other biological factors may all contribute. Researchers are still working to understand how these influences interact.
3. Mental health is part of PMOS care
PMOS is associated with a higher prevalence of anxiety, depression, eating disorders and body-image distress (2). These concerns should not be treated as an afterthought.
Symptoms such as unwanted hair growth, acne, fertility difficulties and unpredictable cycles can affect confidence and quality of life. At the same time, hormonal and metabolic factors may also contribute.
Good PMOS care should therefore consider emotional wellbeing alongside reproductive and metabolic health.
4. PMOS deserves attention beyond fertility
Many people first receive a diagnosis while trying to become pregnant. But PMOS requires care whether or not pregnancy is currently a goal.
Depending on individual risk factors, the condition may be associated with a greater likelihood of impaired glucose regulation, type 2 diabetes, high blood pressure, abnormal cholesterol levels, sleep apnoea and endometrial hyperplasia (2, 3).
This does not mean everyone with PMOS will develop these conditions. It means appropriate screening and preventive care should be part of long-term management.
What should you do if you have, or suspect, PMOS?
There is no single diet, supplement or lifestyle routine that "cures" PMOS. Management should be personalised around your symptoms, health risks and goals.
Track your cycle and symptoms
Record period dates, cycle length and symptoms such as acne, hair changes, mood, sleep and energy. A pattern over several months can give your healthcare provider more useful information than a single snapshot.
Tracking should help you understand your body; not make you feel pressured to achieve a "perfect" cycle.
Ask about metabolic screening
Speak to your healthcare provider about whether you need checks such as blood pressure, cholesterol and glucose testing. These can be relevant even if you are not overweight.
Insulin levels alone are not routinely recommended as a definitive test for diagnosing insulin resistance, so results should always be interpreted in their clinical context.
Do not ignore very infrequent periods
Going for long periods without menstrual bleeding can allow the uterine lining to build up. If your periods are consistently very far apart or absent, speak with a clinician about whether you need treatment to protect the endometrium.
This might include hormonal contraception or periodic progestogen, depending on your needs and medical history.
Focus on sustainable habits
Regular movement, resistance training, adequate sleep and balanced meals containing fibre, protein, fats and carbohydrates can support metabolic and cardiovascular health.
There is no single "best PCOS diet." The most helpful approach is generally one that is nutritionally balanced, culturally appropriate, affordable and realistic enough to maintain.
Discuss treatment based on your priorities
Treatment may differ depending on whether your main concern is irregular cycles, acne, unwanted hair growth, metabolic health or fertility.
Options can include hormonal contraception, metformin, anti-androgen medication, dermatological treatment and ovulation-inducing medication. These should be discussed with a qualified healthcare professional because benefits, risks and suitability vary between individuals.
Does the new name change your diagnosis?
No. PMOS describes the same syndrome previously called PCOS.
You do not need to be diagnosed again simply because the terminology has changed, and your previous test results or treatment plan do not automatically become invalid. During the transition, you may see healthcare providers and websites use "PCOS," "PMOS" or both terms together.
What the new name can change is the conversation.
It moves the focus away from "cysts" and towards the interconnected hormonal, metabolic, reproductive and emotional aspects of the condition. For many women, that broader understanding may feel more accurate, and more validating.
The Ayla takeaway
PCOS becoming PMOS is more than a rebrand. It reflects what women with the condition have long known: their symptoms cannot always be reduced to their ovaries, their weight or their fertility.
The new name creates an opportunity for more complete care, care that listens to symptoms, considers long-term health and recognises that PMOS can look different in every person.
You are not a collection of disconnected symptoms. Your care should not treat you like one.
This article is for educational purposes and does not replace individual medical advice. Speak with a qualified healthcare professional if you are concerned about your cycles, symptoms or metabolic health.
References
- Teede HJ, Khomami MB, Morman R, Laven JSE, Joham AE, Costello MF, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026 May 12. doi:10.1016/S0140-6736(26)00717-8.
- Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-69. doi:10.1210/clinem/dgad463.
- Johns Hopkins Medicine. Polyendocrine metabolic ovarian syndrome (PMOS) [Internet]. Baltimore (MD): Johns Hopkins Medicine; 2026 [cited 2026 Sep 21]. Available from: hopkinsmedicine.org.